Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Aortic Stenosis
NCT05256758Unknown
- Sponsor
- University of Oxford
- Start
- May 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in aortic valve stenosis comparing Fenofibrate Arm with Placebo Arm (2 arms). Primary endpoint: Change in myocardial triglyceride content at 6 months. Status: unknown.
02
Drugs
fenofibrate
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT05256758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05256758.